NCT04245865View on ClinicalTrials.gov

Tocotrienol and Bevacizumab in Metastatic Colorectal Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

June 26, 2020

Primary Completion Date

March 31, 2025

Study Completion Date

December 31, 2025

Conditions
Colorectal Cancer Metastatic
Interventions
DRUG

Fluorouracil

2800 mg/m2 iv

DRUG

Calcium folinate

400 mg/m2 iv

DRUG

Oxaliplatin

85 mg/m2 iv

DRUG

Bevacizumab

5 mg/kg OR 7.5 mg/kg iv

DRUG

Capecitabine

2000 mg/m2 orally daily for two weeks

DIETARY_SUPPLEMENT

Tocotrienol

300 mg orally x 3 daily

OTHER

Placebo

Placebo orally x 3 daily

Trial Locations (1)

7100

Department of Oncology, Vejle Hospital, Vejle

All Listed Sponsors
lead

Vejle Hospital

OTHER